Just this morning it was announced that aesthetics giant Allergan (you probably know it as the brand behind Botox Cosmetic, Juvéderm and Latisse) will be adding another beauty-centric company to its portfolio: Zeltiq Aesthetics, the fat-reducing brand that uses the power of freezing fat in its CoolSculpting device.
You May Also Like: Allergan Spends $90 Million to Buy Company Developing “Topical Botox”
The sale is slated for about $2.48 billion and is strictly for the CoolSculpting device. It’s the latest in a list of companies that Allergan has been acquiring.
“By adding the best-in-class body contouring CoolSculpting System to our best-in-class facial aesthetics, plastic surgery and regenerative medicine offerings, we are creating a world-class aesthetics business,” Allergan CEO Brent Saunders said in a statement. “With CoolSculpting, our offerings to plastic surgeons, dermatologists and aesthetic practitioners will now extend to three of the largest and fastest-growing segments of their practices, putting Allergan in a unique position to provide expanded customer service, and help meet the needs of patients.”
